Results 11 to 20 of about 30,905 (165)
BMC Medical Genetics, 2020 Background Multiple endocrine neoplasia type 1 (MEN1) syndrome is usually accompanied by endocrine tumors, but non-endocrine tumors can occur as well. However, the coexistence of MEN1 syndrome and malignant tumor such as low-grade fibromyxoid sarcoma has
Maja Radman, Tanja Milicevic
doaj +1 more source
Carcinoid syndrome due to a malignant somatostatinoma [PDF]
Postgraduate Medical Journal, 1995 Abstract Somatostatinoma is one of the rarest tumours of the endocrine pancreas. Cardinal manifestations of a somatostatinoma include gallstones, mild diabetes mellitus, steatorrhoea, diarrhoea and dyspepsia. Like any other pancreatic islet cell carcinoma, a somatostatinoma may also produce several different hormones such as ...
O, Ozbakir +6 more
openaire +4 more sources
Bulletin of the National Research Centre, 2019 Background Carcinoids at atypical sites are rare and mostly asymptomatic. In the majority, they show normal levels of serotonin and its metabolites in plasma and urine, resulting in a relatively late diagnosis and hence guarded prognosis.
Karim G. Moustafa, Gamal M. Saied
doaj +1 more source
Expressions of Cushing’s syndrome in multiple endocrine neoplasia type 1
Frontiers in Endocrinology, 2023 Cushing’s syndrome (CS) resulting from endogenous hypercortisolism can be sporadic or can occur in the context of familial disease because of pituitary or extra-pituitary neuroendocrine tumors.
William F. Simonds
doaj +1 more source
Case Reports in Oncology, 2014 Pancreatic neuroendocrine tumors (NETs), including poorly differentiated carcinomas (NECs), are rarely encountered. The majority of these tumors do not secrete excess hormones, but functioning NETs produce large amounts of vasoactive peptides and may ...
Frank Van Fraeyenhove +7 more
doaj +1 more source
Targeted treatment with somatostatin analogues: widening horizons of clinical practice
Alʹmanah Kliničeskoj Mediciny, 2022 Targeted treatment with somatostatin analogues (SA) in acromegaly and neuroendocrine neoplasms may have some benefits compared to curative treatments, because these agents decrease excessive hormone secretion and exert a tumor-suppressive effect ...
Vyacheslav S. Pronin +3 more
doaj +1 more source
MDCT imaging in malignant carcinoid syndrome [PDF]
Indian Journal of Gastroenterology, 2011 A 65-year-old lady presented with sudden onset of palpitations, headache, perspirations and flushing. Clinical examination revealed tenderness in right lumbar region. Ultrasound abdomen revealed multiple hyperechoic hepatic lesions and a mesenteric mass.
Kamini, Gupta +3 more
openaire +2 more sources
Síndrome carcinóide: relato de caso Carcinoid syndrome: case report
Anais Brasileiros de Dermatologia, 2008 Os tumores carcinóides são raros, com incidência aproximada de um a dois casos por 100.000 habitantes. Estima-se que a síndrome carcinóide - que se caracteriza por flushing, diarréia, dor abdominal e, em menor freqüência, pelagra, broncoespasmo e doença ...
Ane Beatriz Mautari Niwa +1 more
doaj +1 more source
Endocrine Oncology, 2023 Ectopic adrenocorticotrophic hormone (ACTH) secretion (EAS) is a rare cause of ACTH-dependent Cushing’s syndrome (CS), most often caused by a thoracic neuroendocrine tumor (NET).
Stéphanie Larose +3 more
doaj +1 more source
Frontiers in Endocrinology, 2017 Ectopic adrenocorticotropic hormone (ACTH) syndrome is a challenging diagnosis only responsible for approximately 10% of Cushing syndrome cases. It has been associated with a variety of benign and malignant tumors including a carcinoid tumor accompanied ...
Kyoung Jin Kim +5 more
doaj +1 more source